Pharma Focus Asia

Pfizer Announces Availability of Rimegepant in Hong Kong for Migraine Management

Tuesday, October 03, 2023

Pfizer has made an announcement regarding the availability of Rimegepant in Hong Kong, marking a significant milestone as it becomes the first Asian market to offer this calcitonin gene-related peptide (CGRP) receptor antagonist for the management of migraines.

Rimegepant has already been successfully launched in more than 39 markets globally, including the United States, the European Union, and the United Kingdom, underscoring its widespread acceptance and use. Furthermore, regulatory authorities in various other regions are currently reviewing applications for its approval.

The Phase 3 clinical trial results have demonstrated the efficacy of Rimegepant in providing substantial relief to migraine sufferers. A single dose of the medication has shown superior effectiveness in reducing pain and alleviating associated migraine symptoms within a two-hour timeframe, outperforming a placebo. 

Another study, has revealed that when taken every other day, Rimegepant significantly reduces the number of migraine days per month during weeks 9 to 12 of a 12-week treatment period in comparison to a placebo.

In Hong Kong, migraine affects approximately 12.5 percent of the population, making it a prevalent health concern. Migraine exhibits a gender bias, with women experiencing it at a significantly higher rate, occurring three to four times more frequently in women than in men.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024